Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-06-21 Sale | 2021-06-23 5:28 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer | 1,777 | $61.61 | $109,481 | 3,555 (Direct) | View |
| 2021-04-16 Sale | 2021-04-20 4:10 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer | 1,118 | $55.89 | $62,485 | 0 (Direct) | View |
| 2021-04-15 Sale | 2021-04-16 4:33 pm | AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer | 991 | $54 | $53,514 | 1,118 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-08-01 Option Award | 2025-08-05 8:42 pm | N/A 2032-01-24 | Prime Medicine Inc. | PRME | Alenson Carman See Remarks | 203,333 | $0 | 203,333 (Direct) | View |
| 2025-02-27 Option Award | 2025-03-03 8:18 pm | N/A 2035-02-27 | Prime Medicine Inc. | PRME | Alenson Carman See Remarks | 90,500 | $0 | 90,500 (Direct) | View |
| 2024-02-21 Option Award | 2024-02-23 5:01 pm | N/A 2034-02-21 | Prime Medicine Inc. | PRME | Alenson Carman See Remarks | 90,498 | $0 | 90,498 (Direct) | View |
| 2023-04-18 Option Award | 2023-04-20 4:28 pm | N/A 2033-04-18 | Prime Medicine Inc. | PRME | Alenson Carman See Remarks | 6,254 | $0 | 6,254 (Direct) | View |
| 2023-03-31 Option Award | 2023-04-04 8:22 pm | N/A 2033-03-31 | Prime Medicine Inc. | PRME | Alenson Carman See Remarks | 90,498 | $0 | 90,498 (Direct) | View |
Ownership | 2022-10-19 8:05 pm | N/A 2031-08-04 | Prime Medicine Inc. | PRME | Alenson Carman See Remarks | 0 | $0 | 151,183 (Direct) | View |
| 2021-06-21 Exercise | 2021-06-23 5:28 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer | 1,777 | $51.51 | 3,555 (Direct) | View |
| 2021-06-21 Exercise | 2021-06-23 5:28 pm | N/A 2030-02-14 | AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer | 1,777 | $0 | 3,555 (Direct) | View |
| 2021-02-22 Tax Withholding | 2021-02-24 4:12 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer | 199 | $0 | 2,486 (Direct) | View |
| 2021-02-22 Exercise | 2021-02-24 4:12 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer | 692 | $0 | 2,486 (Direct) | View |
| 2021-02-16 Tax Withholding | 2021-02-17 4:13 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer | 561 | $0 | 3,079 (Direct) | View |
| 2021-02-14 Exercise | 2021-02-17 4:13 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer | 1,679 | $0 | 3,079 (Direct) | View |
| 2021-02-10 Option Award | 2021-02-12 4:22 pm | N/A N/A | AGIOS PHARMACEUTICALS INC. | AGIO | Alenson Carman Principal Accounting Officer | 8,883 | $0 | 8,883 (Direct) | View |